A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 187
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : ACM
Long Form : all-cause mortality
No. Year Title Co-occurring Abbreviation
2019 Does time from diagnosis to treatment of high- or very-high-risk prostate cancer affect outcome? BCR, IQR, PCSM, RP, VHR
2019 Effect of Dapagliflozin on Heart Failure and Mortality in Type 2 Diabetes Mellitus. CV, EF, HFrEF, HHF, SGLT2i
2019 Evidence-Based Study Design for Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia. APACHE, HABP, VABP
2019 First-year weight loss with androgen-deprivation therapy increases risks of prostate cancer progression and prostate cancer-specific mortality: results from SEARCH. ADT, CRPC, HR, PC, PCSM, RP, SEARCH
2019 Gamma-Glutamyl Transferase-to-Platelet Ratio as a Novel Predictor of Long-Term Adverse Outcomes in Patients after Undergoing Percutaneous Coronary Intervention: A Retrospective Cohort Study. ACS, CAD, CI, CM, GPR, HR, PCI
2019 GENETIC-AF: Bucindolol for the Maintenance of Sinus Rhythm in a Genotype-Defined Heart Failure Population. ADRB1, AF, AFL, ECG, HF, HFrEF, HR, LVEF
2019 Impact of Degree of Left Ventricular Remodeling on Clinical Outcomes From Cardiac Resynchronization Therapy. ACM/HFH, CI, CRT, CRT-D, CRT-P, HFrEF, HR, HR, LV, OPT
2019 Importance of non-regional lymph nodes in assigning risk in primary metastatic prostate cancer. CI, HR, mPCa, NRLN, PCSM
2019 More lymph node dissection improves survival in patients with newly diagnosed lymph node-positive penile cancer. CSM, HR, LND, OS
10  2019 Prognostic Differences in ISUP Grade Group 4: a Systematic Review and Meta-Analysis. Cl, HR, ISUP, PCSM
11  2019 Racial Disparities in the Presentation, Early Definitive Surgical Treatment, and Mortality Among Men Diagnosed with Poorly Differentiated/Undifferentiated Non-metastatic Prostate Cancer in the USA. CSM, RP, SEER, vs
12  2019 Reduction of Cardiovascular Risk and Improved Estimated Glomerular Filtration Rate by SGLT2 Inhibitors, Including Dapagliflozin, Is Consistent Across the Class: An Analysis of the Placebo Arm of EXSCEL. eGFR, EXSCEL, MACE, SGLT2i
13  2019 Relation between therapy-induced changes in natriuretic peptide levels and long-term therapeutic effects on mortality in patients with heart failure and reduced ejection fraction. HFrEF, NPs
14  2019 The impact of psychiatric utilisation prior to cancer diagnosis on survival of solid organ malignancies. CSM, PU, PUG
15  2019 Which treatment is best for patients with AJCC stage IV bladder cancer? BCa, CSM, CSS, CT, HR, OS, RC, RT, SEER
16  2018 A comparison of blood pressure indices as predictors of all-cause mortality among middle-aged men and women during 701,707 person-years of follow-up. BP, DBP, MAP, MBP, MPAP, PP, SBP
17  2018 Breast cancer risk factors, survival and recurrence, and tumor molecular subtype: analysis of 3012 women from an indigenous Asian population. BMI, CIs, FFP, HER2, HRs
18  2018 CHA2 DS2 -VASc score and clinical outcomes of patients with chest pain discharged from internal medicine wards following acute coronary syndrome rule-out. ACS
19  2018 Circulating enterolactone concentrations and prognosis of postmenopausal breast cancer: assessment of mediation by inflammatory markers. BCSM, CRP, DDFS, ENL, HR, IL
20  2018 Clinical characteristics associated with racial disparities in endometrial cancer outcomes: A surveillance, epidemiology and end results analysis. CSM, HR, VBT
21  2018 Definitive Radiation Therapy and Survival in Clinically Node-Positive Prostate Cancer. ADT, CI, HR, PCSM, PSA, RT
22  2018 Generalized Competing Event Models Can Reduce Cost and Duration of Cancer Clinical Trials. CSM, GCE
23  2018 Impact of unresolved neutropenia in patients with neutropenia and invasive aspergillosis: a post hoc analysis of the SECURE trial. EOT, IA
24  2018 ISUP Group 4 - a Homogenous Group of Prostate Cancers? aHR, Cl, ISUP, PCSM
25  2018 Meta-Analysis of Risk of Ventricular Arrhythmias and All-Cause Mortality in Patients With Chronic Total Occlusion of a Coronary Artery and/or Implantable Cardioverter-Defibrillator. CI, CTO, HR, ICD, VAs
26  2018 Neutrophil, lymphocyte and platelet counts, and risk of prostate cancer outcomes in white and black men: results from the SEARCH database. BCR, CBC, CRPC, NLR, PC, PCSM, PLR
27  2018 Obese patients with castration-resistant prostate cancer may be at a lower risk of all-cause mortality: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database. BMI, HR, non-mCRPC, PCSM, SEARCH
28  2018 Outcome of catheter ablation for ventricular tachycardia in patients with ischemic cardiomyopathy: A systematic review and meta-analysis of randomized clinical trials. CA, CVD, ICM, OR, RR, VT
29  2018 Overall mortality of Canadian Armed Forces personnel enrolled 1976-2012. CAF, CFCAMS II, CGP, CLM, ICD, SMRs
30  2018 Partial Nephrectomy versus Thermal Ablation for Clinical Stage T1 Renal Masses: Systematic Review and Meta-Analysis of More than 3,900 Patients. CI, CSM, eGFR, HR, LR, PN
31  2018 Predialysis hyponatremia and mortality in elderly patients beginning to undergo hemodialysis. HR
32  2018 Prognostic Factors for Mortality among Day +100 Survivors after Allogeneic Hematopoietic Cell Transplantation. BM, HCT, HR, RM
33  2018 Prognostic value of exercise capacity among patients with treated depression: The Henry Ford Exercise Testing (FIT) Project. FIT, METs, MI
34  2018 Radical Versus Partial Nephrectomy for cT1 Renal Cell Carcinoma. CSM, HR, OCM, PN, PS, RCC, RN
35  2018 Risk prediction in stable cardiovascular disease using a high-sensitivity cardiac troponin T single biomarker strategy compared to the ESC-SCORE. ACS, AMI, CV, DHF, ESC-SCORE, hs-cTnT
36  2018 Surgery vs Radiotherapy in the Management of Biopsy Gleason Score 9-10 Prostate Cancer and the Risk of Mortality. ADT, EBRT, PCSM, RP
37  2018 Systematic review and network meta-analysis of clinical outcomes associated with isavuconazole versus relevant comparators for patients with invasive aspergillosis. AmB, AmB-D, IA, L-AmB
38  2018 Systematic Review of Comorbidity and Competing-risks Assessments for Bladder Cancer Patients. BC, CRA
39  2018 The Association Between Sarcopenia and Oncologic Outcomes After Radical Prostatectomy. BCR, RP, SMI, SP
40  2018 The impact of buprenorphine and methadone on mortality: a primary care cohort study in the United Kingdom. CI, DRP, IRR, OST
41  2018 The prognostic value of sST2 and galectin-3 considering different aetiologies in non-ischaemic heart failure. CM, DCM, HF
42  2018 Treatment outcomes in patients with proven/probable vs possible invasive mould disease in a phase III trial comparing isavuconazole vs voriconazole. EORTC/MSG, EOT, IMD, TEAEs
43  2018 Variceal Hemorrhage and Adverse Liver Outcomes in Patients With Cystic Fibrosis Cirrhosis. CF, CI, HR, LD, LT, VB
44  2017 Addition of Surgery After Radiation Significantly Improves Survival in Stage IIIB Non-small Cell Lung Cancer: A Population-Based Analysis. CSM, SEER
45  2017 Alterations in microRNA expression associated with alcohol consumption in rectal cancer subjects. CR, HR, LTC, miRNAs
46  2017 An overall and dose-response meta-analysis of red blood cell distribution width and CVD outcomes. CVD, HR, MACEs, RDW
47  2017 Beta-blocker subtype and risks of perioperative adverse events following non-cardiac surgery: a nationwide cohort study. MACE
48  2017 Comparison of the Coronary Artery Calcium Score and Number of Calcified Coronary Plaques for Predicting Patient Mortality Risk. CAC
49  2017 Does exposure to opioid substitution treatment in prison reduce the risk of death after release? A national prospective observational study in England. CI, DRP, HR, OST, OUD, PY
50  2017 Effect of PR Interval on Outcomes Following Cardiac Resynchronization Therapy: A Secondary Analysis of the COMPANION Trial. CRT-D, LBBB, OPT
51  2017 Impact of Exercise on the RelationshipBetween CAC Scoresand All-Cause Mortality. CAC
52  2017 Investigating the prevalence, predictors, and prognosis of suboptimal statin use early after a non-ST elevation acute coronary syndrome. CI, MACE, NSTE-ACS
53  2017 Lack of Diuretic Efficiency (but Not Low Diuresis) Early in An Acutely Decompensated Heart Failure Episode Is Associated with Increased 180-Day Mortality. ADHF, DE, eGFR, HR
54  2017 Machine learning for prediction of all-cause mortality in patients with suspected coronary artery disease: a 5-year multicentre prospective registry analysis. CCTA, DI, FRS, ML, ML, SIS, SSS
55  2017 Meta-analysis of statins in chronic kidney disease: who benefits? CKD, MACE
56  2017 Meta-analysis of studies comparing oncologic outcomes of radical prostatectomy and brachytherapy for localized prostate cancer. BCR, BT, PCa, PCSM, RP
57  2017 New Prostate Cancer Grading System Predicts Long-term Survival Following Surgery for Gleason Score 8-10 Prostate Cancer. BCR, CI, GS, HR, IQR, PCGS, PCSM, RP
58  2017 Predictive modeling of outcomes following definitive chemoradiotherapy for oropharyngeal cancer based on FDG-PET image characteristics. AUC, CRT, DM, FDG-PET, LF, OC
59  2017 Prognostic and discriminative power of the 7th TNM classification for patients with surgically treated papillary renal cell carcinoma: results of a multi-institutional validation study (CORONA subtype project). CSM, papRCC, RCC, TNM
60  2017 Prognostic Significance of Preoperative Anemia in Patients Undergoing Surgery for Renal Cell Carcinoma: A Meta-analysis. CI, CSM, DR, HR, RCC
61  2017 Radical Nephrectomy With or Without Lymph Node Dissection for Nonmetastatic Renal Cell Carcinoma: A Propensity Score-based Analysis. CSM, LND, PS, RCC, RN
62  2017 Serum uromodulin predicts graft failure in renal transplant recipients. BUN, eGFR, GL, HR, ROC, SD
63  2017 The impact of comorbidity and PSA doubling time on the risk of death in men experiencing PSA failure following radiation therapy with or with androgen deprivation therapy for unfavorable-risk prostate cancer. ADT, aHR, CI, DT, OCM, PC, PCSM
64  2017 The impact of digoxin on mortality in patients with chronic systolic heart failure: A propensity-matched cohort study. HF
65  2017 The impact of multidisciplinary care on early morbidity and mortality after heart transplantation. ACR
66  2017 Thresholds for PSA doubling time in men with non-metastatic castration-resistant prostate cancer. CRPC, HRs, PCSM, PSADT
67  2017 Using Machine Learning to Define the Association between Cardiorespiratory Fitness and All-Cause Mortality (from the Henry Ford Exercise Testing Project). CI, LR, ML
68  2017 Validation of the Hematopoietic Cell Transplantation-Specific Comorbidity Index in Nonmyeloablative Allogeneic Stem Cell Transplantation. CI, HCT, HR, NMA, NRM, TLI/ATG
69  2016 Comparative Effectiveness of Renin-Angiotensin System Antagonists in Maintenance Dialysis Patients. ACE, ARB
70  2016 Coronary heart disease mortality, cardiovascular disease mortality and all-cause mortality attributable to dietary intake over 20years in Brazil. CHDM, CVDM
71  2016 Distinct Features of Nonthyroidal Illness in Critically Ill Patients With Infectious Diseases. HPT, ICU, LOS, NTI, TFT
72  2016 Early Fungicidal Activity as a Candidate Surrogate Endpoint for All-Cause Mortality in Cryptococcal Meningitis: A Systematic Review of the Evidence. CM, CSF, EFA
73  2016 Early postoperative C-terminal agrin fragment (CAF) serum levels predict graft loss and proteinuria in renal transplant recipients. BUN, CAF, CAF, GL
74  2016 Effectiveness comparison of cardio-selective to non-selective beta-blockers and their association with mortality and morbidity in end-stage renal disease: a retrospective cohort study. CVMM
75  2016 Epidemiology, pathophysiology, and in-hospital management of pulmonary edema: data from the Romanian Acute Heart Failure Syndromes registry. AHFS, PE, RO-AHFS
76  2016 Gleason Score 3 + 5 or 5 + 3 versus 4 + 4 Prostate Cancer: The Risk of Death. aHR, CI, GS, PC, PCSM
77  2016 Impact of initial local therapy on survival in men later receiving chemotherapy for prostate cancer: a population-based, propensity-weighted multivariable analysis. PCSM, RP, RT, SEER
78  2016 Lower Aorto-Iliac Bifurcation Position and Incident Cardiovascular Disease: A Multi-Ethnic Study of Atherosclerosis (MESA). CI, CVD, HR, MESA
79  2016 Prostate-Specific Antigen Failure and Risk of Death Within Comorbidity Subgroups Among Men With Unfavorable-Risk Prostate Cancer Treated in a Randomized Trial. PC, PSA, RCTs
80  2016 Race and mortality risk after radiation therapy in men treated with or without androgen-suppression therapy for favorable-risk prostate cancer. AA, ADT, aHR, CI, OCM, PC
81  2016 Recurrent Vascular Access Dysfunction as a Novel Marker of Cardiovascular Outcome and Mortality in Hemodialysis Patients. aHR, CV, HD, VA
82  2016 Red cell distribution width and mortality in acute heart failure patients with preserved and reduced ejection fraction. AHF, LVEF, RDW
83  2016 Serum Osmolality and Postdischarge Outcomes After Hospitalization for Heart Failure. HF
84  2016 Statin use and mortality of patients with prostate cancer: a meta-analysis. CIs, HRs, PCa, PCSM
85  2016 The association of serum magnesium and mortality outcomes in heart failure patients: A systematic review and meta-analysis. CI, CV, HF, LV, RR
86  2016 The impact of preoperative anemia on oncologic outcome in patients undergoing radical cystectomy for urothelial carcinoma of the bladder. CSM, DR, PA, RC
87  2016 The impact of timing of salvage hormonal therapy on survival after brachytherapy for prostate cancer. ADT, BCR, CI, HR, PCSM, PSA
88  2016 Triple head-to-head comparison of fibrotic biomarkers galectin-3, osteopontin and gremlin-1 for long-term prognosis in suspected and proven acute heart failure patients. AHF, AHF-RH, ED, HR
89  2016 Validation of the Ability of SYNTAX and Clinical SYNTAX Scores to Predict Adverse Cardiovascular Events After Stent Implantation: A Systematic Review and Meta-Analysis. CAD, CI, MACEs
90  2016 Warranty Period of Zero Coronary Artery Calcium Score for Predicting All-Cause Mortality According to Cardiac Risk Burden in Asymptomatic Korean Adults. CAC, RF
91  2015 All-cause mortality and estimated renal function in type 2 diabetes mellitus outpatients: Is there a relationship with the equation used? CI, eGFR, HRs, OR, ROC, SCr, T2DM
92  2015 Changes in serum potassium levels during hospitalization in patients with worsening heart failure and reduced ejection fraction (from the EVEREST trial). EF, EVEREST, HF
93  2015 Differential effect on survival of pelvic lymph node dissection at radical cystectomy for muscle invasive bladder cancer. CSM, MVA, PLND, RC
94  2015 Differential Impact of Constrictive Physiology after Pericardiocentesis in Malignancy Patients with Pericardial Effusion. CP, HR, PE, RD
95  2015 Effect of perioperative blood transfusion on mortality for major urologic malignancies. CI, CSM, HR, PBT, PN, RC, RP
96  2015 Ischemic biomarker heart-type fatty acid binding protein (hFABP) in acute heart failure - diagnostic and prognostic insights compared to NT-proBNP and troponin I. AHF, AHF-RH, ED, H-FABP, HR, PPV, TnI
97  2015 Preoperative anemia is associated with adverse outcome in patients with urothelial carcinoma of the bladder following radical cystectomy. CSM, DR, Hb, PA, RC, UCB
98  2015 Prognostic Contribution of Exercise Capacity, Heart Rate Recovery, Chronotropic Incompetence, and Myocardial Perfusion Single-Photon Emission Computerized Tomography in the Prediction of Cardiac Death and All-Cause Mortality. CD, EC, HR, SPECT MPS, SSSs
99  2015 Prognostic Significance of Statin Use in Colorectal Cancer: A Systematic Review and Meta-Analysis. CI, CRC, CSM, HR
100  2015 Propensity score matching and persistence correction to reduce bias in comparative effectiveness: the effect of cinacalcet use on all-cause mortality. CI, EVOLVE, ITT, RCTs